TOKYO -- Fujifilm Holdings will invest 700 billion yen ($4.5 billion) by 2028 to expand its biopharmaceutical contract manufacturing business in the U.S. and elsewhere as client pharmaceutical companies outsource more to reduce costs.
Pharmaceuticals
Fujifilm to invest $4.5bn by 2028 in biopharmaceutical plants
North Carolina facility to get more equipment as company boosts capacity fivefold
Fujifilm Holdings is expanding its biopharmaceutical contract manufacturing capacity in the U.S. with an eye on Europe and Japan later. (Nikkei montage/Source photo by Mizuho Miyazaki and courtesy of Fujifilm)
Read Next
Latest on Pharmaceuticals
